The cancer drug is delivered to the target location where we need it to be delivered.The original intention of the development of this drug is that in the traditional cancer treatment, many times the drug cannot reach the tumor site accurately, but will reach other healthy parts of the body, which will bring a series of serious side effects. Through the use of new materials such as nanoparticles and anti-cancer drugs, combined with targeted therapy technology, anticancer drugs can accurately hit the core of the tumor and further improve the effective delivery of the drug.The specific approach is:The first step, based on targeted care, ensures that anticancer drugs actually reach the core of the cancer cell. That is: whether the receptor is first located on the surface of the cancer cell, and the receptor as a marker is unique to the cancer cell, which is equivalent to marking it, and then wrapping the anticancer drug in the nanoparticle to make it The surface receptor can be found to match it. Therefore, targeted therapy is equivalent to giving cancer cells a target that can be applied in real time on almost any type of cancer.In the second step, nanomaterials are used to increase the rate of drug arrival in cancer cells. Why is it related to nanomedicine later? Because some new drugs are targeted at specific cancers, the constituent molecules may be less stable. After entering the body, it may be degraded by the body, and even if it is too late to reach the cancer cells, it has already been broken down by the body. Therefore, we use nanotechnology particles as a new way to encapsulate drugs with nanoparticles, so that drugs can reach the depths of cancer cells."In short, this new nanoparticle-encapsulated anticancer drug can reach the core of cancer cells without harming other healthy cells," said Professor Martina Stenzel.Behind medical progress, there is interdisciplinary communicationThe rise of personalized medicine has made more and more